Non-invasive papillary carcinoma of the bladder associated with carcinoma in situ.

No abstract is available for this paper.

• Publication year

  1976

• Venue

  Journal of Urology

• Publication date

  1976-11-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1016/S0022-5347(17)58916-8PMID 978809
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Mapping cancerous and precancerous bladder changes. A study of the urothelium in ten surgically removed bladders.

  1974cited by this paper
• The clinical significance of carcinoma in situ of the bladder and its association with overt carcinoma.

  1974cited by this paper
• Superficial bladder tumor. Aspects of clinical progression.

  1974cited by this paper
• Benign papilloma or papillary carcinoma of the bladder?

  1973cited by this paper
• Severe atypia of transitional epithelium and carcinoma of the urinary bladder

  1973cited by this paper
• Proliferative and lymphoid reactions in bladder cancer.

  1972cited by this paper
• Proliferative and lymphoid reactions in bladder cancer.

  1972cited by this paper
• Preoperative irradiation as an adjuvant in the surgical management of invasive bladder carcinoma.

  1971cited by this paper
• Carcinoma in situ of the bladder

  1971cited by this paper
• Widespread in situ carcinoma of the bladder with multifocal early invasion. Report of a case subjected to total cystectomy.

  1971cited by this paper
• The role of lymphoid reaction in bladder cancer.

  1970cited by this paper
• The plight of the patient with carcinoma in situ of the bladder.

  1970cited by this paper
• The treatment of bladder tumors.

  1969cited by this paper
• Thiotepa bladder instillations: therapy and prophylaxis for superficial bladder tumors.

  1969cited by this paper
• Pre-cancerous changes in bladder epithelium.

  1968cited by this paper
• Carcinoma in situ of bladder: clinico-pathologic study of case with a suggested approach to detection.

  1966cited by this paper
• CARCINOMA OF THE BLADDER: 20-YEAR EXPERIENCE IN PRIVATE PRACTICE.

  1965cited by this paper
• Natural history and clinical behavior of in situ carcinoma of the human urinary bladder

  1964cited by this paper
• REPORT OF A FOLLOW-UP OF PAPILLARY TUMOURS OF THE BLADDER.

  1964cited by this paper
• Bladder tumors and associated proliferative mucosal lesions.

  1960cited by this paper
• Carcinoma of the bladder: development and evaluation of current concepts of therapy.

  1959cited by this paper
• Radical surgery for carcinoma of the urinary bladder. One hundred consecutive cases four years later

  1956cited by this paper
• The treatment of bladder carcinoma by local excision and fulguration

  1956cited by this paper
• Treatment of histologically benign papilloma of the urinary bladder by local excision and fulguration

  1956cited by this paper
• Intra-urothelial cancer: carcinoma in situ, Bowen's disease of the urinary system: discussion of thirty cases.

  1952cited by this paper
• Histological study of vesical urothelium intervening between gross neoplasms in total cystectomy.

  1952cited by this paper

• Proteogenomics of different urothelial bladder cancer stages reveals distinct molecular features for papillary cancer and carcinoma in situ

  2023cites this paper
• Intraoperative Radiation Therapy

  2023cites this paper
• Development of a predictive model for recurrence-free survival in pTa low-grade bladder cancer.

  2023cites this paper
• Superficial bladder cancer diagnosis — the deliberate choice between fluorescent diagnosis and optical biopsy

  2022cites this paper
• URINE CYTOLOGY AND AXILLARY TESTING FOR INTERPRETATION AND FOLLOW-UP OF URINARY TUMORS

  2022cites this paper
• The Epidemiology of Bladder Cancer.

  2021cites this paper
• Urothelial carcinoma in situ response to cisplatin-based neoadjuvant chemotherapy, or lack thereof: Impact on patient selection for organ preservation in muscle-invasive disease?

  2020cites this paper
• Impact of second transurethral resection on recurrence in patients with high‐grade Ta bladder cancer

  2020cites this paper
• Neoplasms of the Urinary Bladder

  2020cites this paper
• INHIBITION OF UROTHELIAL CARCINOMA BY TYPE I INTERFERON ACTIVATION OF THE INNATE AND ADAPTIVE IMMUNE RESPONSE

  2019cites this paper
• Cytohistologic Correlation of Urothelial Cancers– A study of 57 Cases

  2018cites this paper
• Treatment for Carcinoma In Situ

  2018cites this paper
• Low-Grade, Multiple, Ta Non-muscle-Invasive Bladder Tumors: Tumor Recurrence and Worsening Progression

  2018cites this paper
• The Role and Importance of Timely Radical Cystectomy for High-Risk Non-muscle-Invasive Bladder Cancer.

  2018cites this paper
• Precursor Lesions of Urologic Malignancies.

  2017cites this paper
• Carbonic anhydrase 2 is a novel invasion‐associated factor in urinary bladder cancers

  2017cites this paper
• Relationship between Peripheral Blood Parameters and Stage and Grade of Disease in Patients with Urothelial Cancer of the Urinary Bladder

  2017cites this paper
• Urethral carcinoma in situ: recognition and management

  2017cites this paper
• Incidence and Survival of urothelial carcinoma of the urinary bladder in Norway 1981-2014

  2016cites this paper
• Targeted imaging of urothelium carcinoma in human bladders by an ICG pHLIP peptide ex vivo

  2016cites this paper
• Superficial Bladder Cancer

  2015cites this paper
• BRITISH BIOMEDICAL BULLETIN

  2014cites this paper
• Stem cell marker-positive stellate cells and mast cells are reduced in benign-appearing bladder tissue in patients with urothelial carcinoma

  2014cites this paper
• Histopathological Profile of Bladder Tumors at Tertiary Care Centre in Kashmir - A Comprehensive Six Year Study

  2014cites this paper
• Relevance of the mammalian target of rapamycin pathway in the prognosis of patients with high-risk non-muscle invasive bladder cancer.

  2013cites this paper
• Pathology of flat bladder lesions with emphasis on putative precursors

  2013cites this paper
• Update on the management of non-muscle invasive bladder cancer.

  2013cites this paper
• The Effect of Postoperative Intravesical BCG and Mitomycin C Therapy on Recurrence of Non-Muscle Invasive Bladder Cancer

  2013cites this paper
• Concomitant carcinoma in situ is a feature of aggressive disease in patients with organ confined urothelial carcinoma following radical nephroureterectomy.

  2012cites this paper
• DDX39 acts as a suppressor of invasion for bladder cancer

  2012cites this paper
• Urothelial Carcinoma in Situ

  2012cites this paper
• Treatment of non-muscle-invasive bladder cancer

  2012cites this paper
• Management of non-muscle-invasive (superficial) bladder cancer.

  2012cites this paper
• Best practice in the treatment of nonmuscle invasive bladder cancer

  2012cites this paper
• Prognostic value of cell-cycle regulation biomarkers in bladder cancer.

  2012cites this paper
• Oncolytic Viruses in the Treatment of Bladder Cancer

  2012cites this paper
• Non–Muscle-Invasive Bladder Cancer (Ta, T1, and CIS)

  2012cites this paper
• Oral 5‐aminolevulinic acid in simultaneous photodynamic diagnosis of upper and lower urinary tract transitional cell carcinoma – a prospective audit

  2012cites this paper
• Neoplasms of the Kidney and Bladder

  2011cites this paper
• Survival after primary and deferred cystectomy for stage T1 transitional cell carcinoma of the bladder

  2011cites this paper
• Testing for urinary hyaluronate improves detection and grading of transitional cell carcinoma.

  2011cites this paper
• Wertigkeit von CEA und CA 19-9 in verschiedenen Stadien des Harnblasenkarzinoms: serologische und immunhistochemische Ergebnisse

  2011cites this paper
• Narrow-Band Imaging Flexible Cystoscopy in the Detection of Clinically Unconfirmed Positive Urine Cytology

  2011cites this paper
• Cystectomy for Nonmuscle-Invasive Bladder Cancer

  2011cites this paper
• Important Pathologic Parameters for Reporting Urothelial Carcinoma of the Urinary Bladder

  2011cites this paper
• Urothelial carcinoma of the bladder: definition, treatment and future efforts

  2011cites this paper
• The origins of urothelial carcinoma

  2010cites this paper
• 1to Carcinoma In Situ (CIS)

  2010cites this paper
• Clinical outcome of primary versus secondary bladder carcinoma in situ.

  2010cites this paper
• Incidencias de segundas neoplasias en los pacientes con carcinoma de vejiga no musculoinfiltrante. Implicaciones clinico asistenciales

  2010cites this paper
• Urine Cytologic Analysis: Special Techniques for Bladder Cancer Detection

  2010cites this paper
• Comparison of 2004 and 1973 World Health Organization grading systems and their relationship to pathologic staging for predicting long-term prognosis in patients with urothelial carcinoma.

  2010cites this paper
• Early detection of urothelial premalignant lesions using hexaminolevulinate fluorescence cystoscopy in high risk patients

  2010cites this paper
• Clinical outcomes of primary bladder carcinoma in situ in a contemporary series.

  2010cites this paper
• The origins of urothelial

  2010cites this paper
• Étude des mécanismes régissant l’efficacité photodynamique sélective de l’Héxylaminolévulinate-Protoporphyrine IX dans le traitement du cancer de la vessie : Application dans le cadre de la prévention de ses récidives

  2009cites this paper
• Cystatin B As a Tissue and Urinary Biomarker of Bladder Cancer Recurrence and Disease Progression

  2009influential citation
• Bladder cancer

  2009cites this paper
• The natural history of bladder carcinoma in situ after initial response to bacillus Calmette-Gúerin immunotherapy.

  2009cites this paper
• Cystatin B As aTissue and Urinary Biomarker of Bladder Cancer Recurrence and Disease Progression

  2009influential citation
• Cystatin BAs aTissue and Urinary Biomarker of Bladder Cancer Recurrence and Disease Progression

  2009influential citation
• The Natural History of Non-Muscle-Invasive Transitional Cell Carcinoma of the Bladder

  2009cites this paper
• [Clinical experience with transurethral resection of bladder tumor (TUR-Bt) guided by photodynamic diagnosis (PDD)].

  2009cites this paper
• Clinical outcome of high‐grade non‐muscle‐invasive bladder cancer: A long‐term single center experience

  2009cites this paper
• Approaches to Carcinoma In Situ (CIS)

  2009cites this paper
• Screening for bladder cancer: Theoretical and practical issues in considering the treated and untreated natural history of the various forms of the disease

  2008cites this paper
• Transitional cell carcinoma of the urinary bladder: a clinicopathological study.

  2008cites this paper
• The economic benefit of photodynamic diagnosis in non-muscle invasive bladder cancer.

  2008cites this paper
• Pharmacological treatments for BCG-refractory cancer of the urinary bladder

  2008cites this paper
• Validierung des NMP22®BladderChek als Marker für das Harnblasenkarzinom an der Photodynamischen Diagnostik (PDD)

  2008cites this paper
• Endoscopic image analysis of photosensitizer fluorescence as a promising noninvasive approach for pathological grading of bladder cancer in situ.

  2008cites this paper
• Photodynamic Diagnosis of Superficial Bladder Cancer by using Fluorescence

  2008cites this paper
• Superficial bladder cancer: an update on etiology, molecular development, classification, and natural history.

  2008cites this paper
• A comparison of hexaminolevulinate fluorescence cystoscopy and white light cystoscopy for the detection of carcinoma in situ in patients with bladder cancer: a phase III, multicenter study.

  2007cites this paper
• Retrospective Analysis of Transurethral Resection, Second-Look Resection, and Long-Term Chemo-Metaphylaxis for Superficial Bladder Cancer: Indications and Efficacy of a Differentiated Approach

  2007cites this paper
• Effects of the new Histone Deacetylase Inhibitor PXD101 in Bladder Cancer

  2007cites this paper
• The application of 5-aminolevulinic acid-induced fluorescence for cystoscopic diagnosis and treatment of bladder carcinoma.

  2007cites this paper
• A CRITICAL APPRAISAL OF THE CLASSIFICATION OF UROTHELIAL TUMOURS: TIME FOR A CHANGE, BUT NOT THE CHANGE PROPOSED

  2007cites this paper
• Molecular markers for bladder cancer: the road to a multimarker approach

  2007cites this paper
• [Significance of multiple biopsies obtained from bladder mucosa in renal pelvic and ureteral carcinoma].

  2007cites this paper
• Seven years' experience with 5-aminolevulinic acid in detection of transitional cell carcinoma of the bladder.

  2007cites this paper
• Morphological diagnosis of urothelial neoplasms

  2007cites this paper
• Indikationen zur Urinzytologie

  2007cites this paper
• Clinically relevant reduction in risk of recurrence of superficial bladder cancer using 5-aminolevulinic acid-induced fluorescence diagnosis: 8-year results of prospective randomized study.

  2007cites this paper
• Urological cancers in clinical practice

  2007cites this paper
• The increasing use of intravesical therapies for stage T1 bladder cancer coincides with decreasing survival after cystectomy

  2007cites this paper
• Clinical Condition: Follow-up Imaging of Bladder Carcinoma Variant 1: Superficial TCC-no invasion or risk factors.

  2007cites this paper
• Topical therapy of superficial transitional cell carcinoma of the bladder

  2007cites this paper
• Superficial bladder cancer: part 1. Update on etiology, classification and natural history

  2006cites this paper
• Onkologie und Tumoren

  2006cites this paper
• Enhanced formation of nitric oxide in bladder carcinoma in situ and in BCG treated bladder cancer.

  2006cites this paper
• Urinary hyaluronan as a marker for the presence of residual transitional cell carcinoma of the urinary bladder.

  2006cites this paper
• Current diagnostic and therapeutic methods in the treatment of vesical tumours

  2006cites this paper
• Superficial bladder cancer treated by total cystectomy: Tumour characteristics and patient survival

  2006cites this paper
• Long-term BCG immune therapy of superficial bladder tumours

  2006cites this paper
• Carcinoma in situ and treatment options

  2006cites this paper
• Chemoprevention of bladder cancer

  2006cites this paper
• An Open Pharmacokinetic Study of Hexylaminolevulinate-Induced Photodiagnosis after Intravesical Administration

  2006cites this paper
• Therapy of bladder cancer

  2006cites this paper
• Analysis of tissue ABH antigens in superficial bladder tumours

  2006cites this paper